MedTrace Logo

Triclosan-antibacterial Sutures Impact on the Incidence of Surgical Site Infection in Laparoscopic Surgeries.

NCT04255927 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 912

Last updated 2022-05-11

No results posted yet for this study

Summary

Comparing the incidence of PSI in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in laparoscopic sleeve gastrectomy, laparoscopic appendectomy or laparoscopic cholecystectomy.

Conditions

  • Laparoscopic Surgery
  • Surgical Wound
  • Surgical Site Infection

Interventions

DRUG

Coated Vicryl plus

Vicryl plus (Coated Polyglactin 910 with Triclosan)

DRUG

Coated vicryl

Vicryl (Coated Polyglactin 910 without Triclosan)

Sponsors & Collaborators

  • Misr University for Science and Technology

    collaborator OTHER

  • Al Safwa Hospital

    collaborator UNKNOWN

  • Fayoum University Hospital

    collaborator OTHER

  • ClinAmygate

    lead OTHER

Principal Investigators

  • Emad R Issak, Diploma · ClinAmygate

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-05
Primary Completion
2022-03-10
Completion
2022-04-20
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04255927 on ClinicalTrials.gov